Institute of Applied Radiation Chemistry, Faculty of Chemistry, Lodz University of Technology , Zeromskiego 116, 90-924 Lodz, Poland.
Departament de Química Física i Analítica, Universitat Jaume I , 12071 Castelló, Spain.
J Am Chem Soc. 2016 Dec 21;138(50):16283-16298. doi: 10.1021/jacs.6b06856. Epub 2016 Dec 9.
HIV-1 Protease (HIV-1 PR) is one of the three enzymes essential for the replication process of HIV-1 virus, which explains why it has been the main target for design of drugs against acquired immunodeficiency syndrome (AIDS). This work is focused on exploring the proteolysis reaction catalyzed by HIV-1 PR, with special attention to the dynamic and electrostatic effects governing its catalytic power. Free energy surfaces for all possible mechanisms have been computed in terms of potentials of mean force (PMFs) within hybrid QM/MM potentials, with the QM subset of atoms described at semiempirical (AM1) and DFT (M06-2X) level. The results suggest that the most favorable reaction mechanism involves formation of a gem-diol intermediate, whose decomposition into the product complex would correspond to the rate-limiting step. The agreement between the activation free energy of this step with experimental data, as well as kinetic isotope effects (KIEs), supports this prediction. The role of the protein dynamic was studied by protein isotope labeling in the framework of the Variational Transition State Theory. The predicted enzyme KIEs, also very close to the values measured experimentally, reveal a measurable but small dynamic effect. Our calculations show how the contribution of dynamic effects to the effective activation free energy appears to be below 1 kcal·mol. On the contrary, the electric field created by the protein in the active site of the enzyme emerges as being critical for the electronic reorganization required during the reaction. These electrostatic properties of the active site could be used as a mold for future drug design.
HIV-1 蛋白酶(HIV-1 PR)是 HIV-1 病毒复制过程中必需的三种酶之一,这解释了为什么它一直是设计抗获得性免疫缺陷综合征(AIDS)药物的主要靶点。这项工作主要集中在探索 HIV-1 PR 催化的蛋白水解反应,特别关注控制其催化能力的动力学和静电效应。使用混合 QM/MM 势计算了所有可能机制的自由能表面,其中原子的 QM 子集在半经验(AM1)和 DFT(M06-2X)水平上进行描述。结果表明,最有利的反应机制涉及形成一个 gem-diol 中间体,其分解为产物复合物将对应于限速步骤。该步骤的活化自由能与实验数据以及动力学同位素效应(KIE)的一致性支持了这一预测。在变分过渡态理论的框架内,通过蛋白质同位素标记研究了蛋白质动态的作用。预测的酶 KIE 也非常接近实验测量的值,这表明存在可测量但较小的动态效应。我们的计算表明,动态效应对有效活化自由能的贡献似乎低于 1 kcal·mol。相反,酶活性位点中蛋白质产生的电场对于反应过程中所需的电子重排至关重要。这些活性位点的静电特性可作为未来药物设计的模板。